Investment Bank
An investment bank is a financial institution that provides a broad range of capital markets services to corporations, governments, and institutional investors, including underwriting and distribution of equity and debt securities, advisory services for mergers and acquisitions, market making and proprietary trading, asset management, and sales and research—but does not accept retail deposits or provide traditional commercial banking loans, a distinction formalized by the Glass-Steagall Act (1933) and subsequently blurred by its repeal in 1999.
Key takeaways
- Investment banks earn revenue from underwriting fees (spread between price paid to issuer and public offering price), M&A advisory fees (typically 0.5-2% of deal value), trading profits, and asset management fees.
- The bulge bracket investment banks—Goldman Sachs, JPMorgan, Morgan Stanley, Bank of America, Citigroup—dominate global capital markets league tables and compete for elite mandates across all product lines.
- The Glass-Steagall Act (1933) separated commercial banking from investment banking; its effective repeal via the Gramm-Leach-Bliley Act (1999) allowed universal banking models that combined retail deposits with investment banking activities—a structure blamed for contributing to the 2008 financial crisis.
- Prime brokerage—providing financing, securities lending, and operational services to hedge funds—is a significant and profitable business segment for major investment banks.
- Investment banks face significant conflicts of interest: their research analysts may face pressure to provide favorable coverage of banking clients; their trading desks may trade against client orders; and their M&A advisers may represent competing interests in the same transaction.
Explanation
Investment banking encompasses a diverse array of businesses unified by their focus on providing financial services to institutional and corporate clients rather than retail consumers. The industry originated in the 19th century when merchant banking families (Rothschild, Barings, Lazard) provided capital and advice to railroads, governments, and industrial enterprises, evolving through multiple transformations to reach its current form as a technology-intensive, globally integrated industry dominated by a small number of systemically important financial institutions.
The traditional core of investment banking—capital raising and M&A advisory—remains central to the industry. Equity underwriting involves originating, structuring, and distributing new equity securities (IPOs, secondary offerings, convertible bonds) to institutional investors, with the investment bank typically purchasing shares from the issuer at a slight discount (the underwriting spread) and distributing them to clients at the offer price, earning the spread as compensation. Debt underwriting involves similar functions for corporate bonds, leveraged loans, and structured products. The bookrunning role—serving as lead manager of the syndicate—is the most prestigious and profitable position, typically earning 30-40% of the total underwriting fee for the lead bank.
M&A advisory is the highest-profile investment banking activity, generating substantial fee revenue (0.5-2% of deal value for sell-side advisory, lower for large transactions) and reputational capital that attracts future business. Investment bank M&A teams advise boards and management on transaction strategy, valuation, deal structure, negotiation, regulatory approval, and integration planning. The 'bulge bracket' designation refers to the top-tier investment banks that consistently appear at the top of M&A league tables—Goldman Sachs, JPMorgan, Morgan Stanley, Bank of America Merrill Lynch, and Citigroup—commanding premium fees and attracting the most complex and high-profile transactions.
Sales and trading represents the market-making infrastructure of the financial system. Investment bank trading desks provide liquidity to institutional investors by maintaining two-sided markets (bid and offer prices) in equity, fixed income, foreign exchange, commodity, and derivatives markets. The distinction between 'agency' trading (executing client orders without taking principal risk) and 'principal' trading (acting as counterparty) has been significantly altered by the Volcker Rule, which restricted proprietary trading by banks for their own account. However, market making—taking temporary inventory positions in the course of providing liquidity to clients—is permitted under the rule, and the line between market making and proprietary speculation remains contested.
For hedge funds, investment banks are critical counterparties providing multiple essential services: prime brokerage (securities lending for short selling, leverage financing, custody, and operational services), derivatives dealing (OTC swap counterparty), equity and fixed-income research, IPO allocation, and capital introduction (connecting hedge funds with potential LPs). The prime brokerage relationship is one of the most commercially significant for both parties: large hedge funds provide prime brokers with substantial margin balances and stock loan revenues, while receiving preferential pricing, financing terms, and access to difficult-to-borrow securities in return. The March 2021 collapse of family office Archegos Capital, which owed major prime brokers (Credit Suisse, Nomura, Morgan Stanley, Goldman Sachs) over $20 billion in margin losses from concentrated, highly leveraged positions in media stocks, demonstrated the systemic risk embedded in prime brokerage relationships and prompted significant risk management enhancements across the industry.
Example
In 2023, Goldman Sachs served as lead financial adviser to Pfizer on its $43 billion acquisition of oncology company Seagen. The advisory fee, estimated at approximately $60-80 million (well under 1% of deal value due to the large transaction size), represented one of the largest single M&A advisory fees of the year. Simultaneously, Goldman's investment grade debt capital markets team led the debt financing for the acquisition, raising $31 billion in investment-grade bonds across multiple tranches (earning additional underwriting fees). Goldman's research department published equity research on both Pfizer and Seagen, navigating the information barrier between its banking and research functions. The prime brokerage division serviced hedge funds trading in both companies' stocks around the deal announcement, earning spread and financing revenues on those positions.
Related terms
Debt Financing Equity Excess Spread Exchange Investment Grade Leverage Liquidity Margin Premium Prime Brokerage Proprietary Trading Revolving Credit Facility